Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus

Por Onishi, Yukiko, Koshiyama, Hiroyuki, Imaoka, Takeshi, Haber, Harry, Scism‐Bacon, Jamie, Boardman, Marilyn K
Publicado em 2012

Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24...

Por Kadowaki, Takashi, Namba, Mitsuyoshi, Imaoka, Takeshi, Yamamura, Ayuko, Goto, Wakana, Boardman, Marilyn K., Sowa, Hideaki
Publicado em 2010

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus

Por Ji, Linong, Onishi, Yukiko, Ahn, Chul Woo, Agarwal, Pankaj, Chou, Chien‐Wen, Haber, Harry, Guerrettaz, Kelly, Boardman, Marilyn K
Publicado em 2013

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week...

Por Russell-Jones, David, Cuddihy, Robert M., Hanefeld, Markolf, Kumar, Ajay, González, Jose G., Chan, Melanie, Wolka, Anne M., Boardman, Marilyn K.
Publicado em 2012